Research
Hormonal
Treatment with tesamorelin led to marked reductions in waist circumference and improved lipid levels in a patient with nonobese visceral adiposity.
Tesamorelin may be an effective treatment for reducing visceral fat in specific HIV patients.
StrongSupportsmedium confidence
Treatment with tesamorelin led to marked reductions in WC, improved lipid levels, and enhanced functional well-being.
Why this rating
The abstract provides direct evidence from case presentations.
Source
Differing Presentations of Excess Visceral Abdominal Fat in People Living With HIV: Two Clinical Cases Highlighting Distinct Therapeutic Pathways With Tesamorelin and Glucagon-Like Peptide-1 Receptor Agonists
Robin Beach et al. · Clinical Infectious Diseases · 2026
case_study · n=2Cited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →